Excited to have Hardev Pandha talking about virotherapy for bladder cancer. Opening our final session @_BSGCT
A wonderful talk on #GeneTherapy for motor neuron disorders from @DrJo_Ng at @_BSGCT annual conference this morning.
Incredible to see reversal of debilitating symptoms.
Thrilled to be at #ASGCT23 and to represent Accession Therapeutics. Looking forward to discussing our new platform for delivering #Immunotherapy to difficult cancers later in the week.
Replying to @arjunrajlab @BostonGenomics
What about resubmission, and second choice journal submission?
Apparently writing tools are now co-authors.
I feel like now is the time to introduce my newest team member:
An early start at #ESGCT2022 today after an excellent @_BSGCT /@ESGCT ECR event last night.
Huge thanks to @carlymaybliss for organizing.
Great to see Uta Griesenbach, former @_BSGCT president, recieve her award for service to the society from our new President @RJYanezMunoz. A brilliant way to kick off #ESGCT2022.
Back in Scotland for the @_BSGCT @ESGCT conference.
Can't wait to see everyone in person again! Even the sun has come to join us. #ESGCT2022
Replying to @alanlparker
I've still never got a faster response from you then when I sent you data showing my knob was 10microns across.
*Door flies open* "Well Alex, I can't say I'm surprised!".
Don't go after the NK cells! How will we convince granting agencies we are mere weeks away from off the shelf cell therapies?!
Replying to @klausenhauser
You mean to tell me you can publish virology which is t about SARS-CoV-2?!









